Parameter | PBO/RIS | RIS/RIS | Direct‐enroll | All subjects |
---|---|---|---|---|
(n = 48) | (n = 292) | (n = 50) | (N = 390) | |
SAS total score, mean (SD) | (n = 46) | (n = 180) | (n = 48) | (n = 274) |
Baseline | 0.03 (0.12) | 0.11 (0.24) | 0.17 (0.28) | 0.11 (0.23) |
Change | -0.01 (0.19) | -0.01 (0.28) | -0.05 (0.26) | -0.02 (0.27) |
BARS global rating score, n (%) | ||||
Baseline | (n = 47) | (n = 180) | (n = 48) | (n = 275) |
Absent or questionable | 46 (98) | 173 (96) | 48 (100) | 267 (97) |
Mild to moderate akathisia | 1 (2) | 6 (3) | 0 | 7 (3) |
Marked to severe akathisia | 0 | 1 (1) | 0 | 1 (<1) |
Month 6 end point | (n = 47) | (n = 181) | (n = 50) | (n = 278) |
Absent or questionable | 47 (100) | 176 (97) | 50 (100) | 267 (98) |
Mild to moderate akathisia | 0 | 5 (3) | 0 | 5 (2) |
Marked to severe akathisia | 0 | 0 | 0 | 0 |
AIMS, mean (SD) | (n = 46) | (n = 180) | (n = 50) | (n = 276) |
Baseline | 0.4 (1.3) | 0.6 (1.8) | 0.9 (2.2) | 0.6 (1.8) |
Change | -0.4 (1.3) | -0.2 (1.4) | -0.3 (2.2) | -0.3 (1.5) |
Prolactin, male subjects, mean (SD), ng/mL | (n = 28) | (n = 159) | (n = 28) | (n = 215) |
Baseline | 18.6 (24.7) | 40.4 (26.3) | 55.8 (25.3) | 39.6 (27.6) |
Change | 29.1 (32.6) | 3.7 (28.5) | -6.2 (22.2) | 5.7 (29.8) |
Prolactin, female subjects, mean (SD), ng/mL | (n = 13) | (n = 104) | (n = 18) | (n = 135) |
Baseline | 14.3 (6.7) | 73.6 (43.0) | 100.3 (62.3) | 71.5 (48.5) |
Change | 83.4 (44.7) | 11.5 (43.3) | -14.0 (49.3) | 15.0 (50.1) |
Glucose, mean (SD), mmol/L | (n = 46) | (n = 267) | (n = 46) | (n = 359) |
Baseline | 5.1 (0.5) | 5.1 (0.7) | 5.3 (0.5) | 5.2 (0.6) |
Change | 0.2 (0.8) | 0.1 (1.5) | 0.0 (0.9) | 0.1 (1.4) |
HDL, mean (SD), mmol/L | (n = 22) | (n = 215) | (n = 46) | (n = 283) |
Baseline | 1.0 (0.2) | 1.3 (0.3) | 1.4 (0.4) | 1.3 (0.4) |
Change | -0.04 (0.2) | -0.05 (0.2) | -0.03 (0.2) | -0.04 (0.2) |
LDL, mean (SD), mmol/L | (n = 22) | (n = 214) | (n = 46) | (n = 282) |
Baseline | 2.2 (0.7) | 2.4 (0.7) | 2.3 (0.5) | 2.4 (0.7) |
Change | -0.04 (0.4) | 0.01 (0.6) | 0.04 (0.5) | 0.01 (0.5) |
Total cholesterol, mean, (SD), mmol/L | (n = 46) | (n = 271) | (n = 47) | (n = 364) |
Baseline | 4.09 (1.07) | 4.19 (0.77) | 4.20 (0.71) | 4.18 (0.81) |
Change | 0.02 (0.59) | -0.04 (0.73) | -0.03 (0.61) | -0.04 (0.69) |
Triglycerides, mean (SD), mmol/L | (n = 46) | (n = 271) | (n = 47) | (n = 364) |
Baseline | 1.19 (0.71) | 1.13 (0.58) | 1.21 (0.65) | 1.15 (0.61) |
Change | 0.07 (0.58) | -0.00 (0.64) | -0.09 (0.72) | -0.01 (0.64) |
Leptin, mean (SD), μg/L | (n = 21) | (n = 217) | (n = 47) | (n = 285) |
Baseline | 11.4 (11.1) | 13.1 (14.2) | 12.3 (14.3) | 12.9 (14.0) |
Change | 6.5 (12.8) | 2.0 (9.3) | 2.6 (7.2) | 2.4 (9.3) |
Height, mean (SD), cm | (n = 44) | (n = 278) | (n = 49) | (n = 371) |
Baseline | 163.9 (10.2) | 167.3 (11.4) | 173.0 (9.8) | 167.6 (11.3) |
Change | 0.9 (1.3) | 1.0 (1.6) | 1.1 (1.5) | 1.0 (1.6) |
Weight, mean (SD), kg | (n = 44) | (n = 278) | (n = 49) | (n = 371) |
Baseline | 60.2 (21.3) | 62.6 (13.7) | 67.6 (14.3) | 63.0 (14.9) |
Change | 4.3 (5.5) | 3.9 (5.3) | 4.5 (5.8) | 4.0 (5.4) |
BMI, mean (SD), kg/m² | (n = 44) | (n = 278) | (n = 49) | (n = 371) |
Baseline | 22.0 (5.9) | 22.2 (3.7) | 22.5 (3.9) | 22.2 (4.0) |
Change | 1.4 (1.9) | 1.1 (1.9) | 1.2 (1.7) | 1.2 (1.8) |